These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12697643

  • 1. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
    Seral C, Carryn S, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2003 May; 51(5):1167-73. PubMed ID: 12697643
    [Abstract] [Full Text] [Related]

  • 2. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C, Barcia-Macay M, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [Abstract] [Full Text] [Related]

  • 3. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
    Lemaire S, Van Bambeke F, Tulkens PM.
    Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
    [Abstract] [Full Text] [Related]

  • 4. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
    Vallet CM, Marquez B, Ngabirano E, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
    [Abstract] [Full Text] [Related]

  • 5. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
    Carryn S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2095-103. PubMed ID: 12069960
    [Abstract] [Full Text] [Related]

  • 6. Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.
    Michot JM, Seral C, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2429-37. PubMed ID: 15917543
    [Abstract] [Full Text] [Related]

  • 7. Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.
    Lismond A, Tulkens PM, Mingeot-Leclercq MP, Courvalin P, Van Bambeke F.
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3040-6. PubMed ID: 18573933
    [Abstract] [Full Text] [Related]

  • 8. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.
    Imbuluzqueta E, Lemaire S, Gamazo C, Elizondo E, Ventosa N, Veciana J, Van Bambeke F, Blanco-Prieto MJ.
    J Antimicrob Chemother; 2012 Sep; 67(9):2158-64. PubMed ID: 22615297
    [Abstract] [Full Text] [Related]

  • 9. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.
    Seral C, Van Bambeke F, Tulkens PM.
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2283-92. PubMed ID: 12821480
    [Abstract] [Full Text] [Related]

  • 10. Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.
    Rudin DE, Gao PX, Cao CX, Neu HC, Silverstein SC.
    J Exp Med; 1992 Nov 01; 176(5):1439-47. PubMed ID: 1402686
    [Abstract] [Full Text] [Related]

  • 11. Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.
    Van de Velde S, Nguyen HA, Van Bambeke F, Tulkens PM, Grellet J, Dubois V, Quentin C, Saux MC.
    J Antimicrob Chemother; 2008 Sep 01; 62(3):518-21. PubMed ID: 18544595
    [Abstract] [Full Text] [Related]

  • 12. Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter.
    Michot JM, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    Antimicrob Agents Chemother; 2004 Jul 01; 48(7):2673-82. PubMed ID: 15215125
    [Abstract] [Full Text] [Related]

  • 13. Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections.
    Baudoux P, Bles N, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2007 Feb 01; 59(2):246-53. PubMed ID: 17220162
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.
    Lemaire S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    Antimicrob Agents Chemother; 2007 Aug 01; 51(8):2748-57. PubMed ID: 17548493
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of 7-(4-(Piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity.
    Marquez B, Pourcelle V, Vallet CM, Mingeot-Leclercq MP, Tulkens PM, Marchand-Bruynaert J, Van Bambeke F.
    Pharm Res; 2014 May 01; 31(5):1290-301. PubMed ID: 24306327
    [Abstract] [Full Text] [Related]

  • 16. Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.
    Carryn S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    J Antimicrob Chemother; 2003 Apr 01; 51(4):1051-2. PubMed ID: 12654747
    [No Abstract] [Full Text] [Related]

  • 17. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.
    Krut O, Sommer H, Krönke M.
    J Antimicrob Chemother; 2004 Feb 01; 53(2):167-73. PubMed ID: 14729736
    [Abstract] [Full Text] [Related]

  • 18. Salicylate reduces the antimicrobial activity of ciprofloxacin against extracellular Salmonella enterica serovar Typhimurium, but not against Salmonella in macrophages.
    Hartog E, Menashe O, Kler E, Yaron S.
    J Antimicrob Chemother; 2010 May 01; 65(5):888-96. PubMed ID: 20237076
    [Abstract] [Full Text] [Related]

  • 19. Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.
    Lemaire S, Van Bambeke F, Tulkens PM.
    Antimicrob Agents Chemother; 2009 Sep 01; 53(9):3734-43. PubMed ID: 19564365
    [Abstract] [Full Text] [Related]

  • 20. Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model.
    Nguyen HA, Grellet J, Paillard D, Dubois V, Quentin C, Saux MC.
    J Antimicrob Chemother; 2006 May 01; 57(5):883-90. PubMed ID: 16533826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.